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Abstract 
 
Cancer is classified as the greatest threat to human health in modern times. Currently 
conventional medicine uses chemotherapy as preferential treatment. However, this 
therapy entails acute side effects in patients, largely due to their lack of selectivity. 
Basidiomycetes are well known in the literature for the ability to produce secondary 
metabolites capable of being useful in different biomedical fields, including anticancer 
compounds. In a previous work, Pisolithus tinctorius, a globally distributed fungus 
capable of forming ectomycorrhizas in association with several trees, has already 
demonstrated a potential bioactivity with spores extracts and cancer cell lines. 
Following this work, the main objective of this dissertation was to optimize the 
extraction procedure of P. tinctorius spores, and following a bioassay guided 
fractionation to isolate compounds involved in the cytotoxicity. Initially two extractions 
were carried out only with solvent and sonication, resulting in a low extraction 
efficiency. With this, four different experimental methodologies were carried out to find 
the best extraction technique: extraction using only solvent (1), solvent and glass 
beads (2), solvent and sonication (3) and solvent, glass beads and sonication (4). 
Considering the results obtained, method 2 was selected for use in large-scale 
extraction. By vacuum liquid chromatography, using an increasing polarity gradient, it 
was possible to obtain 9 different fractions per extract. These fractions were tested for   
cytotoxicity by the 3-(4.5-dimethylthiazol-2-yl)-2.5-diphenyltetrazolium bromide (MTT) 
assay and using the cancer cell lines T47D, RKO, HEPG2 and the normal cell line 
HCMEC/D3. Fractions were tested at concentrations of 100, 10 and 1 µg/ ml over the 
24 h, 48 h and 72 h. Due to the low mass recovered, the fractions that caused acute 
cytotoxic were grouped into a single pool, and then subjected to a gravity 
chromatography process (performed in parallel with thin layer chromatography), and 22 
fractions were collected. Nuclear Magnetic Resonance analysis and cell viability assay 
of these fractions was performed to pooling the fractions that displayed the highest 
cytotoxic activity. This pool was subjected to high pressure liquid chromatography 
(HPLC), revealing a complexity, requiring further fractionation to identify and isolate the 
compound(s) responsible for this bioactivity. This study confirms the existence of 
 bioactive compounds with anticancer potential. The optimisation of the extraction 
process using glass beads is a first step in establishing new extraction techniques. 
However, further refinements are necessary to obtain sufficient mass, to be able to 
isolate and identify the compounds responsible for the bioactivity.  
  
 
Resumo 
O cancro é considerado como a maior ameaça para saúde humana nos tempos atuais. 
Atualmente a medicina convencional utiliza a quimioterapia como tratamento 
preferencial. Contudo esta terapia acarreta efeitos secundários nos pacientes, 
derivado em muito a sua falta de seletividade. Os basidiomicetes, são conhecidos na 
literatura pela sua capacidade de produzirem metabolitos secundários com potencial 
farmacológico nomeadamente potencial anticancerígeno. Num trabalho anterior, 
extratos de esporos de Pisolithus tinctorius, um fungo distribuído mundialmente e com 
capacidade de formar ectomicorizas em associações com diversas arvores, revelou 
potencial bioativo em linhagens celulares cancerígenas. Tendo em conta este trabalho 
o principalmente objetivo desta dissertação de mestrado foi otimizar o processo de 
extração com esporos de P. tinctorius e seguindo um fracionamento guiado por 
bioensaio isolar os compostos envolvidos na citotoxicidade. Inicialmente duas 
extrações forma efetuadas apenas com solvente e com a ação de um sonicador, 
resultando numa baixa eficiência de extração. Com isto quatro diferentes metodologias 
experimentais foram efetuadas: Extração com recurso apenas a solvente (1), uso de 
esferas de vidro com 3mm de diâmetro (2), solvente com auxilio de sonicação (3) e 
finalmente a extração com o recurso a esferas de vidro com diâmetro de 3mm, 
juntamente com sonicação (4). Tendo em conta os resultados obtidos, o método 2 foi 
selecionado para ser usado na extração em larga escala. Através de uma 
cromatografia liquida com vácuo, usando um gradiente crescente de polaridade, foi 
possível obter 9 frações distintas por extrato. Estas frações foram sujeitadas a um 
teste de citotoxicidade através de um ensaio com 3-(4.5-dimetilthiazol-2-il)-2.5-
difeniltetrazolium bromedo (MTT), com as linhas celulares cancerígenas T47D, RKO, 
HEPG2 e uma linhagem celular normal HCMEC/D3, em concentrações de 100, 10 e 
1µg/ml durante o período de 24h, 48h e 72h. Devida a baixa massa recuperada, as 
frações que despertavam resultados citotoxicologicos agudos, foram agrupadas numa 
única pool, sendo posteriormente sujeitas a um processo de cromatografia por 
gravidade, (realizado paralelamente uma cromatografia de camada  fina,  sendo 
recolhidos 22 frações e observando o ensaio de viabilidade celular estas frações, 
agrupou-se as que apresentavam maior atividade citotóxica. Esta pool foi submetida a 
uma cromatografia líquida de alta pressão (HPLC), revelando uma complexidade, 
sendo necessário mais um fracionamento de maneira a poder identificar e isolar o 
 composto(s) responsáveis por esta bioactividade. Este estudo vem confirmar a 
existência de compostos bioativos com potencial anticancerígeno. A otimização do 
processo de extração com o recurso a esferas de vidro, representa um primeiro passo 
em estabelecer novas técnicas de extração. No entanto, novos aperfeiçoamentos são 
necessários, de maneira a obter massa suficiente, para assim ser possível identificar e 
isolar os compostos responsáveis por esta bioatividade anticancerígena. 
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1. Introduction 
 
1.1. Basidiomycota and chemical properties;  
Basidiomycota are one of the big divisions of the higher kingdom of Fungi (Moore, 
1998). In this group, we can include a vast number of types of Basidiomycota like 
mushrooms, puffballs, earthstars and other diverse organisms.  Their ability to produce 
countless number of secondary metabolites aroused attention of the scientific 
community to discover the of these new compounds properties. The rise of synthetic 
substances and chemical syntheses did not stop the exploration of natural compounds. 
Furthermore, today, more than ever, the necessity to give response a wide range of 
problems, the search for secondary metabolites with biological activity happens at an 
explosive rate. Therefore, most of the new drugs created by pharmaceutical industries 
are from natural products, with 80% of this medicine having  this origin (Wasser, 2014) 
(Chihara, Maeda, Hamuro, Sasaki, & Fukuoka, 1969). To reinforce the importance of 
these compounds, drugs like antibiotics (penicillin and erythromycin), anti-obesity 
pharmaceuticals (lovastatin) and immunosuppressants (cyclosporin) have their origin in 
secondary metabolites of Basidiomycota 
Distinctive societies use these organisms in their diet, given their marked taste and the 
ease of growth in very extreme environments. Furthermore, they can be composed up 
to 40% of protein of its dry weight, being an excellent source of amino acids, 
possessing a good nutritional value (Money, 2016). Due to these facts, the ancient 
civilizations use the basidiomycotas to treat health problems. Oriental societies were 
pioneers in use of the Shiitake (Lentinus edodes) and Reishi (Ganoderma lucidum) in 
the treatment of different cancers and immunodeficiency disorders. The are other 
reports in the use of the psychadelic mushroom Amanita muscaria in the 
Mesoamerican, Celtic and Russian cultures with purpose of spiritualism and to reach a 
higher level of conscience (Chang & Miles, 1989). However, only with the advent of the 
chemical syntheses and the development of the biochemistry, the researchers started 
to get insights of the mechanisms of actions of these compounds. In 1969, it was 
isolated a polysaccharide, named Lentinan from Lentinus edodes, showing a strong 
anticancer activity in mice sarcoma 180. The isolation of this compound led 
researchers to look to the basidiomycota as new potential source of anticancer drugs.  
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As one of the deadliest disease, cancer is still draw the scientific community to find new 
approaches to fight this illness. In fact, the World Health Organization (WHO) reports 
that cancer is the main cause of mortality in 1 in 6 dead’s and is expected the number 
of oncological patients rise by 70% until 2030.(McGuire, 2016)  
Traditionally, the western medicine relies on chemotherapy as a way to treat cancer. 
However, most of the drugs used in this technic are cytoxic substances, with a lack of 
selectiveness, targeting the normal and the oncological cells to induce the apoptosis. 
As consequence of this aggressive therapy, most patients suffer from side effects with 
immunosuppression, opening a door to opportunistic infections(Patel & Goyal, 2012). 
Nausea and acute pains are usually common, along with an impact in the patient self-
esteem. Most of the drugs with origin in mushrooms are use as complementary of 
chemotherapy and radiotherapy, mostly to stimulate immune system to attack the 
cancer cells and preventing the infections from other diseases. Following this 
problematic, the modern pharmaceutical industry is trying to discover new compounds 
with different mechanisms of actions of the mainstream drugs. The lucrative market of 
the cancer drugs has reallocated most of the funds to the research of the innovative 
therapy’s with experience of the oriental cultures of medical mushrooms (Wasser, 
2014). To reveal the importance, several drugs with origin in mushrooms are covered 
by the Japanese Health System. In 1993 25 % of anti-cancer drugs in the Nippon 
market had origin in mushrooms (Mizuno, 1999). Other study reports that workers from 
edible mushroom farm in Nagamo District (Japan), and consequently their diet were 
based in this Fungi, had a much lower rate of cancer incidence than the general 
population. (Ikekawa, 2001).  
The most studied are the β-Glucans, a type of β-D-glucose polysaccharides, present in 
the cell wall in different organisms, including fungi. Most of this β-Glucans are chains 
glucose polysaccharides connected by β-type glycosidic bonds (Lemieszek & Rzeski, 
2012; Ren, Perera, & Hemar, 2012). Proteins can be connected in the side chains 
creating molecules like polysaccharide-K (PSK). This polysaccharide is extracted from 
a basidiomycota called Trametes versicolor and some studies show the potential of 
PSK to be used as adjuvant in the treatment of several cancers like leukaemia, breast 
and liver cancer. This compound is able to stimulate the instigation of natural killer 
cells, T-cells, dendritic cells and induce the production of cytokines. (Fritz et al., 2015). 
Although β-Glucans are well known in literature, secondary metabolites produce by the 
fungi can have a beneficial effect rising the interest from the therapeutic view. 
Compounds like terpenoids, triterpenoids, lactones and alkaloids have been identified 
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has potential anti-cancer drugs. (Petronelli, Pannitteri, & Testa, 2009). Some of this 
compounds are capable to interfere with intracellular pathways, like panepoxydone, 
Extracted from Lentinus crinitus, panepoxydone can inhibit the DNA binding of nuclear 
factor kappa-light-chain-enhancer of activated B cells (NF‐κB) (Arora et al., 2014; 
Erkel, Anke, & Sterner, 1996). The deregulation of this molecular mechanism is a 
characteristic of many cancers and compounds inhibitors of NF‐κB can be used to 
mediate inflammatory process and hold the cancer cells proliferation.(Sethi, Sung, & 
Aggarwal, 2008). Moreover, enzymes with antioxidant potential has been documented, 
such as superoxide dismutase, glucose oxidase and peroxidase. The presence of 
these enzymes can help the cells to deal with reactive oxygen species (ROS’s), 
highlighting the importance of the fungi to prevent damages from oxidative stress. (Wei, 
Helsper, & Van Griensven, 2008; Wei & Van Griensven, 2008). 
 
 
Figure 1-Mechanisms of action from the anticancer compounds from fungi (Wasser, 2014) 
 
These compounds can be obtain from different parts from the fungi with diverse 
extraction processes, being available to the pharmaceutical market: (Wasser, 2014). 
1. Extracts from freeze dried fruit body powders. 
2. Extracts from freeze dried mycelium; 
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The constant demanding for new compounds with bioactive response put some 
pressure on pharmaceutical industry. In this perspective, Wasser, 2014 established a 
protocol called Drug Discovery Procedure, to put a standard process to discover new 
therapeutic drugs.  
 
Figure 2. The bioassay-guided fractionation process (Wasser, 2010; Weller, 2012) 
 
Although these results are accepted in Eastern world, the scepticism in the Western 
Medicine can be explain by the rigid regulation enforced in these countries (Wasser, 
2014) The lack of standardization and safety protocols can jeopardize the safe use of 
these compounds. The absence of information, leads Wasser, 2014 to also question if 
the bioactive effects are caused by an isolated compound or a group of them with a 
synergistic action. Other highlighted problem is the possibility of the compounds 
extracted from fungi interact with common used drugs, leading to unknown side effects. 
 
Biomass 
Production
Biomass 
extraction
Chemical 
Fractions
Screening for 
toxicity
Chemical  
Elucidation 
Clinical drug 
development
3. Biomass or extracts from mycelium from liquid culture grown in a bioreactor; 
4. Spores and their extracts; 
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1.2. Pisolithus tinctorius; 
 
Pisolithus tinctorius (Pers.) Coker & Couch 1928 belong to basidiomycota phylum and 
to the Sclerodermataceae family. They have the ability to establish a symbiotic 
relationship with host trees, boosting their grow and development (Marx, 1977). The 
structure of P. tinctorius can be divided in two main regions: sporocarp, the zone 
connected to the soil, with a hard and rigid texture; and an upper zone with soft tissue 
called pseudoperidioles, containing a brownish pigment and the spores of this fungus. 
This organism can reach 20 cm of diameter,(Coker & Couch, 1928) weight up to 1 kg, 
with the spores size range between 7 to 11 μm (De Zubiria, Horner, & Lehrer, 1990). 
Due to large spectrum of heterogeneity in the morphology and with the help of DNA 
sequence data, some authors question the actual classification (Cairney, 2002). 
Furthermore, the results from (Martin, Diez, Dell, & Delaruelle, 2002), state that P. 
tinctorius is not a so called “pan-global super fungus”, but a complex of multiple 
species with more restrict geographical presence and limited host. 
The ectomycorrhizal relationship is also essential to invasive tree species to colonise 
new habitats, with the prominent cases being the introduction of eucalypts in the 
Iberian Peninsula (Díez, 2005) or the invasion of Pinus species in 
Australia.(Richardson, 2000). In both cases, Pisolithus played a big role in contributing 
to the success of the invasion. 
Highly used in reforestation, ectomycorrhizal fungi, such as P. tinctorius are key to the 
success of silviculture programs. The formation of fungal hyphae permits a deeper 
penetration in the soil allowing more efficient uptakes of N and transport to the host 
(Oliveira, Franco, & Castro, 2012). (Peay, Bruns, Kennedy, Bergemann, & Garbelotto, 
2007) stated that the fungi can provide 86% of the N host need’s and receive 15% of 
carbohydrates. Nutrients are not the only benefit the host can receive. Since the 
ectomycorrhizas have a tolerance to high concentration of heavy metals, P. tinctorius 
showed a potential to be use for bioremediation of contaminated soils (Tam, 1995). 
The formation of the hyphal net around the host roots can serve of physical barrier 
preventing predators and pathogens to attack the tree. P. tinctorius have an important 
role in producing compounds with anti-fungal and anti-bacterial activity providing an 
extra protection. (Tsantrizos, Kope, Fortin, & Ogilvie, 1991).  
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This result, highlighted the possibility of use the secondary metabolites in diverse fields 
of the biomedical sciences, boosting the research on understanding all bioactive 
potential of P. tinctorius. 
 
 
1.3. Bioactive potential of Pisolithus 
 
As was stated before, nowadays the main potential of P. tinctorius is centrally in the 
economic value due to the ability to boost reforestation programs. This interaction host-
fungi increases the concentration of certain compounds, as terpenes, in the host whose 
function is to protect it against fungal infections (Abreu, 1987). For this motive, studies 
were done to verify the presence of allelochemicals, in other words, secondary 
metabolites that can influence the growth of other organisms. The presence and the 
understanding of these compounds in P. tinctorius can open doors to new approaches 
in biomedical fields as the constant resistance to antibiotics and the search for new 
compounds, to be used as fungicides, explore the possible potential as antioxidant or 
even inhibit the grow of cancer cells as was demonstrated by Montenegro et al., 2004 
 
1.3.1. Anti-cancer potential 
As was describe before, cancer is considered of the most problematic disease that we 
face off. The actual therapies had demonstrated low efficiency with high collateral 
effects for the patients. Consequently, there has been a constant focus and growing 
interest from researchers to find new useful compounds to fight this infirmity. To verify 
the anticancer potential of P. tinctorius, some studies were made, especially with 
pisosterol, a compound primarily isolated by Gill, Kiefel, Skelton, & White, 1989, which 
is a triterpene present in the sporecarp of the fungus.  
Montenegro et al. in 2004 conducted the first study concerning the anticarcinogenic 
action of pisosterol. This triterpene was tested in vitro, in erythrocytes of rats, sea 
urchin’s eggs and in the human cancer cell lines, such SF-268, B16, PC-3, MCF-7, 
HCT-8, HL-60 and CEM. By recurring to MTT assay, the authors were able to verify the 
mitochondrial activity of the cancer cell lines. Data revealed, membrane disruption in 
mouse erythrocytes was not observed and pisosterol has not interrupted the 
development of the sea urchin eggs. However, there was a strong growth inhibition in 
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all cancer cell lines, more notably in leukemia and melanoma cells. The same authors 
suggests that the selectivity have a different mechanism of action than the common 
cytotoxic drugs. 
With this data, Montenegro and his team in 2007, conducted a study to determine if 
pisosterol was able to induce differentiation using HL-60 cell lines (leukemia cells) and 
normal cells peripheral blood mononuclear cells (PBMC). The data showed that HL-60 
cells treated with pisosterol tended to differentiate into monocytic cells. Apoptosis was 
detected in HL-60 cells exposed to pisosterol, despite no cytotoxicity was observed in 
PBMC cells, even in the highest concentration (5 μg/ml), suggesting that pisosterol can 
be selective to cancer cells lines and revealing the potential of this compound to be 
used in the cancer treatment. This study was determinant since it is essential to 
evaluate the damages in the dividing proliferating lymphocytes, to prevent collateral 
damages. (Anazetti, Melo, Durán, & Haun, 2003) 
The cancer cell HL-60 genome has a proto-oncogene called C-MYC, located in the 
homogeneously staining region (HSR) 8q24 aberration and has an important function 
on regulating the cell life cycle. It is known that, cancer cells with low degree of 
expression of C-MYC are less aggressive and so, more susceptible to chemotherapy 
treatment. (Eckhardt et al., 1994; Fegan, White, & Sweeney, 1995). It was observed 
that 90% of the analysed cells lacked this HSR region when threated with pisosterol. 
Consequently, these results opened the possibility of the use of pisosterol combined 
with chemotherapy, since this compound has the ability to block aggressive 
mechanisms of certain cancers. 
Pisosterol was also tested in human glioblastoma cell lines.(Pereira et al., 2011) These 
type of cancer cells are known for their acute aggressiveness with an unfortunately, 
average rate survival of one year after being detected (Pinto et al., 2009). The study 
used two different cell lines, U343 and AHOL1, and before the treatment, 72% of U343 
and 65% of AHOL1 cells registered more than two alleles of C-MYC. By being exposed 
to 1.8 µl/ml of pisosterol, only 33% of U343 cells and 15% of AHOL1 cells showed 
signs of containing C-MYC, signifying that pisosterol also blocks the expression of this 
proto-oncogene. 
Since there was no data regarding the anticancer activity of pisosterol in in vivo assays, 
Montenegro et al., 2008 conducted a study where Sarcoma 180 tumours were 
transplanted to Swiss female mice and treated with 50 mg/m2 and 100 mg/m2 of 
pisosterol. The results showed that this compound was able to inhibit tumour growth by 
43%. Morphological exams were made to evaluate the influence of pisosterol on the 
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mice organs. The treatment had an impact in the liver, showing kupffer cells 
hyperplasia, focal infiltrate of inflammatory cells, centriolobular vennus congestion, 
demonstrating that the liver is a target organ of pisosterol. Although, the authors 
concluded that the damages can be reversible since no stromal fibrosis was detected 
and conjunctive tissue was preserved. 
 
Figure 3. Chemical structure of Pisosterol 
 
 
Most of the studies that were done, have use the mycelium or the sporecarp to perform 
extraction, ignoring other structures of P. tinctorius such as the spores. The inoculation 
of the spores, through an allergy skin test, had provoked an allergy symptoms in 9% of 
the subjects (De Zubiria et al., 1990). Workers from silviculture industry and college 
students were subjected to the skin prick test with spores extracts. The workers group 
was the most affected, with 28.2% showing positive reactions, and 82% of individuals 
from these positive tests developed symptoms of respiratory allergy. The authors 
stated that, since this basidiomycete is used to boost reforestation, the exposure to 
spores can be considered a possible occupational hazard by provoking respiratory 
allergic asthmas. 
Considering the absence of data in the literature, regarding the bioactivity potential of 
the P. tinctorius spores, (Alves, Preto, Vasconcelos, Oliveira, & Martins, 2015) 
conducted a work to assess the presence of anticancer substances. Firstly, it was 
evaluated which solvent had the major yield extraction and less mitochondrial activity. 
The result showed that the mixture of DCM:MeoH (2:1) had the best yield considering 
the mitochondrial activity. Starting from the crude extract, through successive bioassay-
guided fractionation, 11 fractions were screened for cytotoxicity in MG63 (bone 
osteosarcoma),T47D (human breast tumour), RKO (rectal carcinoma) cell lines and 
simultaneity with normal endothelial cells. The data revealed a decrease in cancer cell 
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viability with a low impact in the normal cells. n other hand, considering the very low 
yield of extraction, it was not possible to purify, identify and isolated the compound(s), 
responsible for the anticancer response. So Alves et al., 2015 suggested in further 
studies, improving the extraction technique to help isolate the active compound. 
 
 
1.3.3. Antimicrobial Potential 
The discovery of penicillin has opened a new era in modern medicine, giving us the 
possibility to fight a large spectrum of diseases caused by bacteria (Golkar, Bagasra, & 
Pace, 2014). The massive use of antibiotics has lead us to an increasing resistance of 
the bacteria to these compounds. Some authors state this is probably the biggest 
threat to the human public health in the XXI century (Ventola, 2015). The statistics 
shows that more people die in USA of diseases provoked by methicillin-resistant 
Staphylococcus aureus (MRSA) than HIV/AIDS, Parkinson’s disease, emphysema, and 
homicide together. (Golkar et al., 2014; Rossolini, Arena, Pecile, & Pollini, 2014). 
Therefore, it has been an intense research to find new compounds that demonstrate 
efficiency to fight the so called super bugs, and fungi are a promising source for this 
type of drugs. 
The first report of antimicrobial activity from P.tinctorius came from Kope and Fortin in 
1989, when antifungal activity in cell free cultures was observed, provoking hyphal lysis 
to a different organisms. To understand the mechanism behind this activity, Tsantrizos 
et al., in 1991 isolated the pisolithin A and pisolithin B from P.tinctorius mycelium. . 
Although these metabolites were know in the literature, there was no data about their 
antifungal potential. These compounds showed a great capacity to reduce the mycelial 
grow of several phytopathogenic fungi such as Rhizoctonia praticola, Truncatella 
hartigii, Sphaerosporella brunnea, Fusarium solani, Brunchorstia pinea and 
dermatopathogenic like Microsporum gypseum and Trchophyton equinum. The authors 
noticed also that the inhibition was similar, and in some cases higher than antifungal 
chemical agents such as nystatin and polyoxin D. 
Tackling the problematic of the resistance of the bacteria’s to the antibiotics, Ameri, 
Chanchala, Vaidya, & Deokule in 2011, conducted a study with crude extract and 
isolated fractions of P. albus against strains of MRSA. The collected fungi where 
associated with Acacia auriculiformis and Eucalyptus globulus trees. The crude was 
extracted with ethyl acetate, methanol and water and the fracts were from zones of 
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diterpenoids, triterpenoids, sesquiterpenoids, and polysaccharides I, II, IIIA and IIIB. 
The results showed that the crude extract with ethyl acetate and methanol had a strong 
antibacterial activity. Likewise, the fraction containing sesquiterpenoids displayed a 
robust action with the minimal inhibitory concentration determined to be in a range of 
0.62 to 1.2 mg/ml. The author declared that with these results there are potential to the 
secondary metabolites of P. albus be use as antimicrobial drugs against certain strains 
of resistant bacteria. It also interesting to highlight the fact of P. albus collected from 
Acacia auriculiformis, did not show any pronounced activity against the majority of 
MRSA strains, proposing the possibility of that different hosts can induce the 
production of diverse compounds. More recently, an assay was conducted with 
extracts of eight species of ECM fungi (including P. albus) for tested anti-fungi potential 
against nine types of plant pathogenic fungi. It was observed that Pisolithus had an 
inhibitory effect in average 33.27% of those plant pathogenic fungi.(Mohan, Nivea, & 
Menon, 2015a) 
 
1.3.5. Other bioactivity potentials: 
Regarding the basis that supports the possibility of an immunosuppressive potential in 
fungal compounds, (Fujimoto, Nakayama, Nakayama, & Yamazaki, 1994) was 
responsible for isolating and characterising the components, using three different 
species of mushrooms, including P. tinctorius. With this fungus, he extracted 
compounds such as pisolactin and ergosterol peroxide, where the IC50 was evaluated 
in relation to the proliferation of lymphocytes in rat spleens stimulated with 
concanavalin A and lipopolysaccharides.  
Additionally, in 2011, the antioxidant potential was also unveiled. In aerobic organisms, 
free radicals are constantly being produced during natural cell metabolism, and there 
are compounds that can counteract undesirable forms of active oxygen in the body, 
detoxifying it. For that effect, (Reis, Ferreira, Barros, & Martins, 2011), did a 
comparative study between tocopherol composition and the antioxidant properties of 
the fungus in vivo and in vitro, using fruiting bodies and mycelia respectively, obtaining 
as a result a high antioxidant capacity resulting from P. tinctorius, mainly when using 
the corresponding structure of mycelia  (Reis et al., 2011))
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Extract/Compound 
Fungal 
structure 
Fungal 
species 
Assay  Biological activity Reference 
Pisosterol 
 
 
 
 
 
Mycelium; 
Sporecarp 
P. tinctorius 
MTT (Montenegro et al. 2004;  
Montenegro et al. 2007) 
NBT reducing activity (Montenegro et 
al. 2007) 
Naphthyl acetate esterase activity 
(Montenegro et al. 2007) 
Antiproliferative effect (inhibition of 
DNA synthesis)  Montenegro et al. 
2007) 
Mitotic index (Burbano et al. 
2007;Pereira et al. 2011) 
In vivo assay (Montenegro et al. 2008) 
 
 
 
 Anticancer 
(Montenegro et al., 2004) 
(Montenegro et al., 2007) 
(Burbano et al., 2009); 
(Carvalho Montenegro et al., 
2008); 
(Pereira et al., 2011) 
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Pisolithin A & Pisolithin B Mycelium P. tinctorius 
 
Spore Inhibition 
 
 Antifungi (Tsantrizos et al., 1991) 
Pisolactona Sporecarp P. tinctorius 
Proliferation of mouse spleen 
lymphocytes stimulation with 
concanavalin A 
Lipopolysaccharide 
 Immunosuppressive (Fujimoto et al., 1994) 
Crude extracts Sporocarp P. albus Well agar diffusion method  Antibacterial (Ameri et al., 2011)
 
Crude extracts Mycelium P.albus 
Well agar diffusion method 
Chitinase activity 
 Antibacterial 
(Mohan, Nivea, & 
Menon, 2015) 
Crude and Fraction 
extracts from spores 
Spores P. tinctorius MTT Assay  Anticancer (Alves et al., 2015) 
Mycelium and Spores 
extracts 
Mycelium; 
Spores 
P.tinctorius Prick-test  Allergenicity (Chavasco et al., 1997) 
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Tocopherols 
Mycelium; 
Sporocarp 
P.  arhizus  
DPPH radical-scavenging 
Activity 
Reducing power and inhibition 
of b-carotene bleaching 
 
(Reis et 
al., 2011) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
Table 1 Pisolithus compounds known for having bioactive properties 
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2. Aim and outline of this dissertation 
 
 
All data collected until now supports the possibility of P. tinctorius to be used has a source 
of compounds with interesting bioactivity properties. Most of the studies were done with 
sporocarps as the source of fungal material, leaving the bioactive potential spores 
unexplored. The work performed by Alves et al. (2015) opened a door to explore this part 
of the fungus, more precisely its anticancer potential. Considering this, and the study 
executed by the main objective of this master thesis was to improve the extraction method 
from P. tinctorius spores, to obtain higher yield efficiency and to obtain more data about 
the compounds responsible for the cytotoxicity.   
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3. Materials and Methods 
 
 
 
3.1. Collection of Pisolithus tinctorius spores 
In order to obtain samples of P. tinctorius, the method used by Alves et al. (2015) was 
followed. Fungi were collected from a forest ecosystem located in the north of Portugal, 
well known for the presence of this species. The P. tinctorius specimens were cut into 
small pieces, and the pseudoperidiole was lyophilised for 48 h, to dry the samples. After 
lyophilisation the spores were isolated with a help of a sieve with a pore of 1 mm. 
 
3.2. Crude extraction and fractionation 
Two extractions were performed following the method used by Alves et al., 2015. The 
spores were extracted with Dichloromethane-Methanol (2:1), through a sonication 
process. They were given the code names of PT01 and E15094. The conditions of the 
crude and fractionation are described in the table 5. 
 
3.3. Improving the extraction technique 
The low extraction yield with P.tinctorius spores obtained by the procedure already 
described, led to the necessary improvement of the method. In this sense, a step that 
uses glass beads was included. The use of glass beads to lyse cell walls and membranes  
is extensively used, as in the DNA extraction from cyanobacteria (Dederich et al., 2002; 
Mehta, Evitt, & Swartz, 2015). (Dederich et al., 2002; Mehta et al., 2015). Using this 
principle, a protocol was established to verify if the glass beads were useful to improve the 
extractions from spores, with four different experimental conditions. Sample 1 was 
extracted only with the solvent, dichloromethane-methanol in the proportion of 2 to 1. 
(DCM:MeOH (2:1)). Secondly, in sample 2 the same solvent mixed with 40 glass beads 
with a diameter of 3 mm. Next, with sample 3, the spores were extracted with DCM:MeOH 
(2:1) with the help of sonicator (Q55 Sonicator). Finally, the sample 4 was submitted an 
extraction the solvent DCM:MeOH (2:1) with the glass beads plus sonication. All the 
samples were extracted in 3 cycles with a duration of 5 minutes of sonication each with 10 
minutes of rest (in part to avoid the over-heating, and to give time to the solvent penetrate 
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in spores) in a plastic tube of 50ml. Particularly, the sample 2 and 4 were subjected to 
agitation with vortex, to force the mechanical lysis through the glass beads. At the final of 
each cycle, the supernatant was decanted to 4 plastics tubes. After all the cycles were 
completed, the samples were left to rest during 24h, and the supernatants were transfer to 
pre-weighted vials with the assistance of a Pasteur pipette. These vials were evaporated 
under reduced pressure, with a rotary evaporator (Buchi Rotavapor® R-100) and the 
recovered weight was calculated. The vials were weighed before and after placement of 
each crude extract in order to calculate the extraction yield. The weight of spores used in 
each condition and volume of solvent used are describe in the Tables 6 and 7. Giving the 
results obtained using only the glass beads, this procedure was repeated for the 
subsequent preparation of extracts. 
 
 
3.4. Full scale extraction with glass beads method 
Given the obtained higher performance of extraction with glass beads, they were chosen 
to perform mechanical lyses. Instead of performing a full extraction, it was decided to 
extract the spores with small quantities and volumes of solvent, in order to optimise the 
solid/solvent ratio. With an average of 800 mg per plastic tube, the spores were extracted 
with 30 ml of DCM:MeOH (2:1) in 2 cycles with 40 to 50 glass beads with 3 mm of 
diameter. During each cycle, the tubes were agitated with a vortex for 5 min, and then 
allowed 5 min to rest. At the end of the sequence, the supernatant was decanted to a 
glass flask. Totally, 61.29g of spores were extracted with a total volume of 2250 ml of 
DCM:MeOH (2:1) mixture. After 24h, the supernatant was retired to a glass balloon, 
carefully with the help of Pasteur pipettes not to perturb the deposit in the bottom of the 
flask. Next, the solvent was evaporated under reduced pressure, with a rotary evaporator 
and transferred with chloroform into pre-weight vial and evaporated again. This crude 
extract, with the code name E16152, was stored in a pre-weight vial, and the recovered 
mass and the respective yield calculated. 
 
3.5. Fractionation of the E15094, PT01 and E16152 crude extract. 
All crude extracts were fractioned through vacuum liquid chromatography method (VLC) 
(Targett, Kilcoyne, & Green, 1979). The 5g of silica gel (Merkel 0.015-0.040) were packed 
hard with support of vacuum and the crude extracted was transferred into the top of the 
column and 400ml of hexane were continually being added until the column absolved all 
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extract compounds. Continuing, a series of different mixtures with increasing polarity was 
charged in the column, until obtaining 9 distinctive fractions. (A with lowest polarity and I 
with highest). The mixtures of solvents and their volumes, along with each mass 
recovered from the fraction are described in the Tables 6, 7 and 8. The fractions were 
collected in round bottom flask and all the solvents were dried under reduced pressure, in 
a rotary evaporator. The dried fractions were dissolved in chloroform and transferred to 
pre-weight vials and evaporated again to determine the weight of the dried mass. 
 
 
3.6. Sub-Fractionation of PTAFCES 
The fractions with higher anticancer activity had such low masses, that isolating and 
testing the compound(s) responsible for that response would prove very difficult. 
Therefore, it was decided to collect all the fractions with higher activity from E15094, 
E16152, PT01 and E14030 (this extraction was performed by (Alves et al., 2015)) in a 
single collection called PTAFCES. Table 2 describes which fraction were pooled together 
and their mass. 
 
Table 2. Composing fractions of PTAFCS and total mass obtained 
Extraction code Fractions Total mass (mg) 
E14030 G, H 
133.43 
E15094 F, G 
PT01 E, F, G 
E16152 E, F, G 
 
 
All the mass of the PTAFCES were sub-fractionated through a chromatography column. 
Here it was used 20g of silica gel (Merkel 0.015-0.040) as stationary phase and a variety 
of solvents mixtures with increasing polarity as mobile phase. In total 187 test tubs were 
collected in seven different elution mixtures (Table 3). Previously to this, Thin Layer 
Chromatography (TLC) was performed to establish the mobile phase that result in better 
separations of the compounds present in the extract. Later TLC was used to identify the 
tubes to mixture in the same pool. Under this technique, a small sample (10 to 20 µL) of 
the fraction was collected from every 5 tubes with a capillary, and put in a TLC plate. The 
same plate was placed in a TLC chamber with the mobile phase with increasing polarity, 
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to drag the most polar substances. All the spots present were verified under a UV light 
and marked with a pencil. 
 
Table 3. Mixing ratio, volume and type of solvents used to perform the gravitational chromatography from 
PTAFCES 
Tubes Solvent Mixing ratio (%) Volume (mL) 
1-46 Hex- EtOAc 60-40 300 
47-62 Hex- EtOAc 50-50 100 
63-106 Hex- EtOAc 40-60 300 
107-127 Hex- EtOAc 30-70 100 
123-138 Hex- EtOAc 20-80 100 
139-155 Hex- EtOAc 10-80 100 
156-171 EtOAc 100 100 
172-187 EtOAc-MeOH 50-50 100 
 
It was analysed the spots marked on the TLC and regroup the tubes solutions by the 
presence of the same, or very similar compounds. This reorganization outcome in 22 
fractions, resulting of being transferred to pre-weighted vials, evaporated under reduced 
pressure, and calculated the recovered mass. (Table 4) 
 
Table 4. Fraction obtained with each tube and total mass recovered from PTAFCES chromotography 
Fractions Tubes Mass (mg) Total mass recovered (mg) 
1 1-5 0.76 
105.35 
2 6-8 2.31 
3 9-11 1.01 
4 12-17 2.42 
5 19-30 26.83 
6 31-39 8.56 
7 40-46 6.84 
8 47-50 2.9 
9 51-62 8.51 
10 63-67 3.06 
11 68-76 4.10 
12 77-89 2.29 
13 90-101 2.03 
14 102-124 2.71 
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15 125-133 1.27 
16 134-142 1.14 
17 143-154 1.22 
18 155-168 1.26 
19 169-175 0.51 
20 176-179 10.09 
21 120-181 7.41 
22 182-187 8.07 
 
 
 
 
3.7. Preparation of the test samples  
From the crude extractions and the fractions E15094, PT01 and E16152 a test sample at 
a concentration of 100mg/ml were prepared. The dried weight was dissolved in chloroform 
in a vial, and from this solution successive dilutions were done in order to prepare other 
concentration test of 10mg/ml and 0.1mg/ml. These vials were evaporated using a 
nitrogen stream and 100 μl of dimethyl sulfoxide (DMSO) were added to each vial. The 
fractions from the collection PTAFCES were under the same process, with the exception 
that a unique concentration of 0.2mg/ml was prepared. 
 
3.8. Preparation of the PTAFCES for nuclear magnetic resonance 
spectroscopy (NMR) 
To verify the purity and to evaluate the chromatography efficacy observe the chemical 
structure of the compounds present in each sample, the 22 fractions from PTAFCES were 
submitted to 1H NMR analysis. Each NMR tube was pre-washed with acetone, chloroform 
and methanol to eliminate the presence of contaminants and dried thoroughly in high 
vacuum. Each fraction was solubilized in deuterochloroform and loaded into the prepared 
NMR tubes. Each fraction was solubilized in deuterochloroform (CDCl3) and loaded into 
the prepared NMR tubes. The 1H NMR spectroscopy was carried out at Centro de 
Materiais da Universidade do Porto (CEMUP), using a BRUKER AVANCE III 400 MHz, 
9.4 Tesla to perform this assay. 
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3.9. Chromatographic scan using High Pressure Liquid 
Chromatography (HPLC) of PTAFCES samples 
In the results from the cytotoxic essay, revealed a strong cytotoxic activity in the fractions 
12-19. When these results were compared with NMR spectra, it was possible to identify 
some common peaks, showing the identical compounds are present in different fractions. 
Given this, the PTAFCES 12-19 was submitted to High Pressure Liquid Chromatography 
(HPLC) to verify the chromatography profile of this set of fractions. The 10µl of PTAFCES 
12-19 was injected in a Synergi 4u Fusion-RP 80A 250x10mm column, with a flow of 
2.0ml/min, with absorbance read at 280 nm and 254 nm, with an isocratic mixture of 100% 
MeCN. It is important to note it was only injected the soluble part in MeCN, with other part 
being preserved. 
 
3.10. Cell Cultures 
The cytotoxicity of samples was tested against 3 cancer cell lines and 1 normal cell line: 
• T47D (human breast cancer cell line); 
• RKO (human colon adenocarcinoma cell); 
• Hep G2 (hepatocyte carcinoma); 
• hCMEC/D3. (human brain capillary endothelial cells) 
Cells were incubated at 37ºC with a 5% CO2 humidified atmosphere, and culture medium 
was renewed every 2 days. When flask fill up with 80% cell confluence, adherent cells 
were free with TrypLE Express Enzyme (Gibco and culture medium was renewed every 2 
days. Considering this, the T47D cells were purchased from Sigma-Aldrich, RKO and Hep 
G2 cell lines were obtained from the American Type Culture Collection (ATCC) and finally 
the hCMEC/D3 were provided by Dr. P. O. Couraud (INSERM,France). Cells were grown 
in Dulbecco’s modified Eagle’s medium (DMEM, GlutaMAX, Life Technologies), pH 7.4, 
supplemented with 10% fetal bovine serum, 2.5 μg/ml fungizone, and penicillin–
streptomycin (100 IU/ml and 100 μg/ml, respectively). 
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3.11. Cell viability assay 
The (4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide (MTT) reduction assay 
is a colorimetric test to measure mitochondrial activity. In this context, the mitochondria’s 
are responsible to reduce this yellow dye into formozan purple crystals and so, the 
absorbance of this colored solution can be read by a microplater reader (van Meerloo, 
Kaspers, & Cloos, 2011). This mitochondrial activity can be proportional to cell viability 
considering the 100% viability in the control (cells treated with 1% DMSO). For the cell 
viability assay, the cells were seeded with a density of 3,3x104 cel/ml in triplicate in 96 well 
plates (previously counted in a Neubauer chamber). After 24h of incubation, the medium 
was removed and 1μl of the fractions samples diluted in 100 μl of fresh medium was 
inserted, to cells being expose to 100, 10 and 1 μl/ml (the PTAFCES samples were tested 
at 20 μl/ml) during 24h, 48h and 72h. Furthermore, were establish positive controls (cell 
being exposure with medium and 1% of DMSO) and negative controls (cells treated with 
medium and 20% of DMSO). After this period of exposure, the cells were treated with 10 
μl of MTT at a concentration of 0.05mg/ml with an incubation period of 4h. After this time, 
the cell medium was retired and 100 μl of DMSO were added to solubilize the purple 
formazine salts. The absorbance of these crystals was measure with microplate reader 
(Bio-tek Synergy™ HT) at of 550 nm, and results expressed as a percentage of cell 
viability considering 100% viability in the control cells. 
 
3.12. Statistical Analysis   
 
Microsoft Office Excel 2016 was used to treat the data from MTT assay. The results are 
presented as means ± standard deviation (SD) from three independent experiments, 
when compared with control results. The same software was used to display the data 
graphically. 
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4. Results  
 
4.1. Improving the extraction technique 
 
Improvement of the efficiency of the extraction was crucial to obtain sufficient mass to use 
a bioactivity assay guided isolation of compounds (using anticancer assays) and to 
perform the characterization of the same substances. The four-different conditions of 
extractions resulted in distinct extraction yields. Additionally, all the experimental 
conditions used the same volume of solvent mixture, submitted to the same time cycles, 
(with some slight differences in the weight of spore’s due to the scale sensitivity). Giving 
this, the standard extraction (sample 3)  previously used by Alves et al., 2015  had 
resulted in 7.50 % of efficiency, being the lowest yield among the four, contrasting with the 
highest obtained with 40 glass beads plus sonication (17.71%). The use of only solvent to 
perform the extraction had given a yield of 8.61% and the use of the 40 glass beads 
resulted in an yield of 16.5%. Ideally, sample 4 would show the highest efficiency 
extraction and logical the first choice to be use in the final extraction, however the method 
used with sample 2 was chosen to perform the large-scale extraction.  
 
Table 5. The four-different conditions of experimental extractions and respective recovered mass and 
efficency yield 
Sample Condition 
Cycles 
and time 
Solvent 
volume (ml) 
Solvent 
Spores 
weight 
(mg) 
Weight 
after the 
extraction 
(mg) 
Extraction 
Yield (%) 
1 Only solvent 
3 cycles; 5 
min each 
20 ml each 
cycle; 60 ml 
in total 
DCM:MeOH 
(2:1) 
109.9 7.9 8.61 
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2 
40 glass 
beads 
3 cycles; 5 
min each 
with 
agitation 
by vortex 
20 ml each 
cycle; 60 ml 
in total 
DCM:MeOH 
(2:1) 
97.2 16.1 16.5 
3 Sonication 
3 cycles; 5 
min 
submitted 
in 
sonication 
20 ml each 
cycle; 60 ml 
in total 
DCM:MeOH 
(2:1) 
96.2 7.8 7.50 
4 
40 glass 
beads; 
Sonication 
3 cycles; 5 
min with 
agitation 
by vortex; 
2 min 
submitted 
to 
sonication 
20 ml each 
cycle; 60 ml 
in total 
DCM:MeOH 
(2:1) 
112 15.8 17.71 
 
 
 
 
 
 
4.2. Fractionation of the E15094, PT01 and E16152 crude extract  
Following the extraction method of Alves et al. (2015) it was possible to obtain two crude 
extracts, as cited above, with the codenames of E15094 and PT01, with yields of 1.9% 
and 2.2%, respectively. After a detail observation of the fractionation table data of E15094 
(Table 6), it is possible to verify that 1.9% of the biomass was recovered with the standard 
protocol by Alves et al., 2015. Using this polarity gradient and looking to the results from 
Alves et al., 2015 this VLC was performed to obtain nine fractions with different weights 
between them. Fraction A and I represented more than half of the total weight, with 23.5% 
and 32.4%, respectively. Contrasting these results the fractions B (10.0 mg) and C (12.2 
mg) denoted the lowest weight fractions.  
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Table 6. Data about E15094 fractionation through VLC and extraction procedure  
 
 
 
 
Results from the extraction and respective fractionation of PT01 (Table 7) revealed a light 
increase of the yield by 0.3 % when compared with the E15094. This same extract was 
divided in nine fractions, following the same weight pattern, with the fraction B and I 
having most mass of the extract. Furthermore, the fractions D, E, F and G only totaling 
13.35 mg, represent 1.3% of the total mass of the extract. The use of glass beads in the 
extraction process, almost duplicated the yield when compared with the previous extracts. 
With an efficiency of 4.0%, it was possible to recover 2388mg of extract, distributed in 9 
fractions. After a more detailed observation of Tables 6, 7 and 8, it is possible to affirm, 
that the fractions A and I are the ones with more mass, comparing with F and G, which 
are the fraction that contain less mass. Nevertheless, these fractions have more mass 
when comparing with the ones from PT01. 
 
Extract 
name 
Spores 
weight 
(g) 
Recovered mass 
(mg) and yield 
extraction (%) 
Fractions Solvent 
Mixing 
ratio (%) 
Volume 
(mL) 
Fractions 
mass (mg) 
E15094 
 
50.0 
950; 
1.9% 
 
A 
Hex- 
EtOAc 
90-10 200 223.6 
B 
Hex- 
EtOAc 
80-20 100 10.0 
C 
Hex- 
EtOAc 
60-40 100 12.2 
D 
Hex- 
EtOAc 
50-50 100 34.3 
E 
Hex- 
EtOAc 
40-60 100 127.6 
F 
Hex- 
EtOAc 
20-80 100 104.5 
G EtOAc 100 150 40.0 
H 
EtOAc-
MeOH 
75-25 150 89..2 
I MeOH 100 300 308.1 
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Table 7. Data about PT01 fractionation through VLC and extraction procedure 
 
 
 
When compared with the glass beads extraction E16152 (2388mg) with a yield of 4.0%, 
the recovered weight of the E15094 and PT01 (950mg and 977mg) was considered very 
low, proving that this method improves the spore’s extractions in large-scale extractions. 
 
 
 
 
 
Extract 
name 
Spores 
weight 
(g) 
Recovered mass 
(mg) and yield 
extraction (%) 
Fractions Solvent 
Mixing 
ratio (%) 
Volume 
(mL) 
Fractions 
mass (mg) 
PT01 
 
44.42 
977mg 
2.2% 
 
A 
Hex- 
EtOAc 
90-10 400 139.93 
B 
Hex- 
EtOAc 
80-20 250 202.53 
C 
Hex- 
EtOAc 
60-40 250 12.46 
D 
Hex- 
EtOAc 
50-50 250 3.16 
E 
Hex- 
EtOAc 
40-60 250 4.95 
F 
Hex- 
EtOAc 
20-80 250 3.01 
G EtOAc 100 250 2.23 
H 
EtOAc-
MeOH 
75-25 250 47.81 
I MeOH 100 500 597.11 
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Table 8. Data about E16152 fractionation through VLC procedure 
Extract 
name 
Spores 
weight 
(g) 
Recovered mass 
(mg) and yield 
extraction (%) 
Fractions Solvent 
Mixing 
ratio (%) 
Volume 
(mL) 
Fractions 
mass (mg) 
E16152 
 
61.29 
2388mg 
4.0% 
 
A 
Hex- 
EtOAc 
90-10 400 427.60 
B 
Hex- 
EtOAc 
80-20 300 159.94 
C 
Hex- 
EtOAc 
60-40 250 220.61 
D 
Hex- 
EtOAc 
50-50 250 129.9 
E 
Hex- 
EtOAc 
40-60 250 60.66 
F 
Hex- 
EtOAc 
20-80 250 25.47 
G EtOAc 100 250 15.51 
H 
EtOAc-
MeOH 
75-25 250 82.0 
I MeOH 100 600 642.38 
 
 
 
 
 
 
4.3. The NMR spectra from the PTAFCES. 
The NMR analyses from PTAFCES fractions showed multiple peaks differing between the 
22 fractions. Therefore, the analyses (Figure 4) revealed that the fractions still complex, 
with the presence of multiple compounds. However, some common peaks were found, 
generally between the fractions 12-19, with some variance in the strength of the signal. It 
was possible to observe the presences of doublets at 7.90 δ, 7.59 δ and quartet 7.10 δ. 
Additionally, in all PTAFCES NMR spectra it is possible to observe strong signals, with 
singlets at 7.26 δ and 3.49 δ 
 27 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4. NMR spectrum from the 22 fractions of PTAFCES fractions. 
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4.4. Results from the chromatograph scan 
 
Figure 16 presents the chromatograph profile of the extraction collection PTAFCES, with 
the blue and the red line representing the absorbance at 280 nm and 254 nm, 
respectively. In the chromatograph is possible to verify the presence of numerous peaks 
in the two wavelengths, in specific between the 6:00min and 23:00min. For instance, the 
first detected peak had a one strong signal, noticed at 6:30 min, corresponding to the 
solvent injection peak. 
 
 
 
280 nm (280.00 nm)
254 nm (254.00 nm)
A
U
0.0000
0.0002
0.0004
0.0006
0.0008
0.0010
0.0012
0.0014
0.0016
0.0018
0.0020
0.0022
0.0024
0.0026
0.0028
0.0030
0.0032
0.0034
0.0036
Minutes
2.00 4.00 6.00 8.00 10.00 12.00 14.00 16.00 18.00 20.00 22.00 24.00 26.00 28.00 30.00 32.00 34.00 36.00 38.00 40.00 42.00 44.00 46.00 48.00 50.00 52.00 54.00 56.00 58.00 60.00 62.00 64.00
Figure 16. Chromatographic profile of the PTAFCES 12-19 pool. The blue and the 
red line represents the absorbance at 280 nm and 254nm respectively. 
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Figure 5. Bioassay guided fractionation design used in this study 
 
 
 
 
4.5. Cell viability results 
 
4.5.1. Cell viability results from E15094 
 
The E15094 fractions were tested for cell viability at a concentration of 10µg/ml with time 
of exposure of 24h and 48h.  Giving this, the figure 8 shows the effects of the fractions in 
the in the cancer and HCMEC/D3 cell viability. Regarding the T47D cell viability, the 
fraction A and I are the less toxic with 86% of the cells being viable after 48h. In other 
hand, only the 10% and 12% of the cells were viable when treated with the fraction F and 
G during 48h. The exposure of the RKO cell lines to the fraction A and I manifest less 
toxicity, with 73% and 74% of viability after 24h, with a slight increase 85% and 89% after 
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48h, respectively. Moreover, the fractions E and F demonstrate the strongest decrease of 
the cell viability (12% and 11% after 48h), with no relevant differences between the time 
exposure. Following the same pattern of the results obtained in HCMEC/D3. The data 
demonstrate that fractions A and I exhibit an increase of the number of the viable cells, 
superior to the control group in 120% after 24h of exposure, then dropping to 72% and 
78% after an exposure of 48h, being the ones with less impact in the viability of the 
HCMEC/D3 cells. On contrary, the exposure of the fractions E and F result in only 38% 
and 37% of the cells were viable after 48h. In fact, by prolonging for 48h, the results are 
more acute with the viability being 13% and 14%, respectively. 
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4.5.2. Cell viability results from PT01 
The figures 7-10 illustrates the cell viability from exposure of nine fractions (in 100µg/ml, 
10µg/ml and 1 µg/ml) from PT01 in four cell lines, during three-time periods. Concerning 
the effects of the fractions on viability of the T47D cells (Figure 7), it is clearly visible that 
the highest concentration provokes the lowest number of viable cells after 72h, more 
specifically the fractions C, D, E, F, and G. Yet, fractions E, F and G can still reduce 
drastically the viability the cell when exposed to the lowest concentration (1µg/ml) to 12% 
at 72h. It is also important to note, that in fraction I it was noticed an increase of the 
number of viable cells when compared with the control in all concentrations, more 
precisely 74% at 1µg/ml. It is also interesting results from fraction B, show to be more 
active in lowest concentration than other highest two.  
 
Figure 6. Effects of fractions from E15094 in 10µg/ml in the viability of HDMC 
(A), RKO (B) and T47D (C) Values are present as means ±SD of triplicate analyses 
when compared with control group (n = 3). 
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Regarding the RKO cell lines (figure 8), the most active fractions are the C, (the Fraction 
C in 1µg/ml showed low impact on the cell viability) D, E, F and G at 72h. On the contrary, 
it is possible to observe a cellular proliferation, when treated with the fractions A and I and 
compared with control, displaying no signs of being toxic at that concentration test. 
 
Figure 7. Effects of fractions from PT01 in 100µg/ml (A), 10µg/ml (B) and 1µg/ml 
(C) in the viability of T47D. Values are present as means ±SD of triplicate analyses 
when compared with control group (n = 3). 
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Next, the fractions E, F and G prove to reduce the cell viability significantly in the HEPG2 
even in the lowest concentration, with only 6%, 12% and 14% viable cells, respectively 
Figure 8. Effects of fractions from PT01 in 100µg/ml (A), 10µg/ml (B) and 1µg/ml 
(C) in the viability of RKO. Values are present as means ±SD of triplicate analyses 
when compared with control group (n = 3). 
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after 72h (Figure 9). As like the other cancer cells, the fraction I stimulated the growth of 
HEPG2 cells, when tested at a concentration of 100µg/ml and 10µg/ml. 
 
 
 
 
 
 
 
Figure 9. Effects of fractions from PT01 in 100µg/ml (A), 10µg/ml (B) and 1µg/ml 
(C) in the viability of HEPG2. Values are present as means ±SD of triplicate 
analyses when compared with control group (n = 3). 
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Finally, the HCMEC/D3 cells (Figure 10) were particular affected by the exposure to all 
tested concentrations. Moreover, the fraction F showed to be the most toxic in all the 
concentrations tested after 72h of treatment. The data revealed also a non-time 
dependent response, with the cellular viability being specifically severe at 42h, increasing 
steadily in the 72h period.  
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4.5.3. Cell viability results from E16151 
The figure 11-14 exhibits the cellular viability from four diverse cell lines, during three-time 
periods, when exposed to three different test concentrations of nine fractions of E16151 
extract. 
Concerning this assay with T47D cell lines (Figure 11), the fractions C, D, E, F, G, H and I 
showed a pronounced toxicity when treated with 100µg/ml after 72 h. Moreover, the 
fraction E proved to be the one to cause less cellular viability (12%). The same pattern 
repeats when exposure to 10µg/ml, except for the H and I, that exhibits a cellular 
proliferation when compared with the control group. At the lower concentration, most of 
the test fractions stimulated the cellular viability, excluding the fractions E, F and G, with a 
cell viability of 54%, 77% and 55% after 72h, respectively. 
 
Figure 10. Effects of fractions from PT01 in 100µg/ml (A), 10µg/ml (B) and 
1µg/ml (C) in the viability of HDMC. Values are present as means ±SD of triplicate 
analyses when compared with control group (n = 3). 
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The data demonstrates that the results from RKO are similar to T47D (Figure 12). The 
most active fractions are C, D, E, F, G, H and I after 72h in the higher test concentration. 
The viability had a vigorous increase in the fraction H and I, being observed stimulation of 
the number of viable cells, when exposed to 10µg/ml. Although, the RKO cells when 
treated with 1µg/ml, showed high cell viability, with the most the fraction G, the most 
active 
Figure 11 -Effects of fractions from E16151 in 100µg/ml (A), 10µg/ml (B) and 
1µg/ml (C) in the viability of T47D. Values are present as means ±SD of triplicate 
analyses when compared with control group (n = 3). 
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Figure 12. Effects of fractions from E16151 in 100µg/ml (A), 10µg/ml (B) and 
1µg/ml (C) in the viability of RKO. Values are present as means ±SD of triplicate 
analyses when compared with control group (n = 3). 
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Following the HEPG2 cell lines, (Figure 13) the most active fraction were E, F and G with 
only 5%, 6% and 5%, respectively were viable after 72h in the highest concentration. As 
expected, when the cells are treated with 1µg/ml, show a higher viability when compared 
with other higher concentrations, being the fraction E the most toxic for the cells (23%). 
On this data it is clearly perceptible, a time-dependence for effects on the cellular viability. 
In fact, the toxic effects are more pronounced as the time of exposure is longer. 
 
 
 
 
 
 
 
Figure 13. Effects of fractions from E16151 in 100µg/ml (A), 10µg/ml (B) and 
1µg/ml (C) in the viability of HEPG2. Values are present as means ±SD of triplicate 
analyses when compared with control group (n = 3). 
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Finally, the data relative of the HCMEC/D3 (Figure 14) cell viability exhibits time-
dependence response in all fractions (with exception of fraction I when treated with 10 
µg/ml and 1µg/ml). In the concentration of 100 µg/ml, the fraction D were the most active 
fraction (17%), contrasting with the test concentration of 10 µg/ml where the fraction D 
cause the lowest number of viable cells after 74 h. It is also important to state that no 
toxicity was verified after being exposure to all concentrations in a time of 24 h. 
 
 
 
 
 
Figure 14. Effects of fractions from E16151 in 100µg/ml (A), 10µg/ml (B) and 
1µg/ml (C) in the viability of HDMC. Values are present as means ±SD of triplicate 
analyses when compared with control group (n = 3). 
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4.5.4. Cell viability results from PTAFCES 
The figure 15 illustrates the data on the cellular viability in two cell lines (HEPG2 and 
HCMEC/D3) when exposed to the 22 fractions that compose the PTAFCES extract 
collection at 20 µg/ml concentration. The fractions 4 to 18 caused low cellular viability in 
HEPG2 line, being the fraction 11 the most toxic after 72 h (9% of the cells were viable). 
This group of fractions showed a time-dependence response, since the increasing time of 
exposure, reduce the cellular viability. On the other hand, the fraction 21 and 22 exhibited 
no toxicity and even induced cellular proliferation.  
Regarding the HCMEC/D3 cell lines, the fractions 4, 5, 6, 7, 9, 10, 11, 12, 13, 15, 16 and 
17 provoked noticeable low cell viabilities after 72 h, with a typical response of a time-
dependence. Moreover, observing the data about the cell viability it is possible to affirm 
that fraction 9 was the most toxic of the 22 tested fractions. Regardless of this, in fractions 
8 the number of viable cells are the same as the group control, reporting no toxicity in all 
the three-time periods. Finally, the half the cells that were tested with fraction 9 were 
viable, after 24 h,48 h and 72 h. 
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5. Discussion 
 
 
Alves et al., 2015 were the first in the literature reporting the potential presence of 
bioactive compounds in P. tinctorius spores and given the lack of data, it was essential to 
establish an extraction method with better efficiency. In this work, an extraction yield of 
2.94%, was obtained, which was considered low, considering the small masses of the 
active fractions obtained. As new in the present work was the use of small glass (or 
zircon) beads to break tick structures such as cyanobacteria cellular membrane (Mehta et 
al., 2015), disrupt bacteria spores (Altmeyer et al., 2012) or even to perform DNA 
extractions (Dederich et al., 2002). E15095 and PT01 were performed according to Alves 
et al., 2015, resulting in very low yield. Associate with this was the fact that most active 
fractions, were the ones with lower masses. (with the example of the fraction G from 
E15094 representing just 1.92% of total mass of the extract), it was imperative to optimize 
the extraction process. 
So, observing the four different extractions (table 5), the sample 4, should be selected for 
the large-scale extractions for having the highest yield extraction. However, the use of the 
glass beads with sonication, with small mass and volumes (in order to optimize the 
surface/solvent ratio) would not prove to be time efficient, consequently resulting in 
logistical problems. Therefore, the difference between this method extraction and the one 
with only glass beads was consider negligible. 
The results from extraction performed in small scales, are generally more efficient than 
the ones made in large scales. Taking into account the experience to choose the best 
extraction solvent, Alves et al., 2015 obtained a yield of 16.3% in a small scale, when in 
the final extraction only 2.94% of the initial mass was recovered. In this study, the same 
reduction of efficiency was verified. In the large scale, the extraction rate was reduced by 
75% when compared with small scale, resulting in a efficiency of 4%. The increase of the 
ratio surface/volume in the extraction method could be an explanation of the low efficiency 
of the process. Maintaining this ratio and performing this extraction with 61.29g of spores 
it would be necessary to use 33.43L of the solvent mixture of DCM:MeOH (2:1). Using this 
volume, it would prove to be an economical and logistical issue, as well as handling such 
amounts could result in chemical hazard and jeopardize the laboratorial safety. The 
extraction of the E16152 to be proved be more efficient by increasing 2.1% and 1.8% 
when compared with ones performed in the E15094 and PT01, respectively. This 
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represents a step in the improvement of the process and confirms that this method can be 
used as baseline in other future extractions. Yet, this technique could achieve more 
improvements to increase more the extraction yield. Extraction of more biomass combined 
with the reduction the ratio surface/volume would prove good options to optimize the 
process. The 3 mm glass beads used in this extraction, were the ones also applied to 
force the lyses in cyanobacteria’s. Vandeventer et al., 2011 stated that the diameter of the 
beads is crucial for increasing the yield extraction and 100 μm zirconia beads were more 
efficient than larger diameter beads on lysing Gram-positive bacteria or even bacteria 
spores (Cohn et al., 1957; Käser, Ruf, Hauser, Marsollier, & Pluschke, 2009). In this 
perspective, downgrading the diameter and use a different material of beads could be a 
good solution. A good idea might be reutilizing the collected evaporate solvent, and use 
them again to perform a new extraction, permitting to save the use of new solvent mixture. 
A detailed observation on the data concerning the VLC demonstrate that most of the 
recovered masses were in the last fractions, that is, the most polar ones. This leads to 
conclude most of the compounds that were extracted from the spores have a more affinity 
to polar solvents. Besides, since the last mobile phase was is constituted by 100% MeOH, 
some silica from the stationary phase could be dissolved in the solvent, turning to have 
more mass than expected. (Edwards et al., 2004) Following the results of the gravitational 
chromatography performed on PTAFCES, it is possible to observe a losing of 28.05mg of 
this original mass, obtaining in the final of the process 105.35mg. Due to the interaction of 
the compounds with silica combined with a low velocity of the chromatography, some of 
the substance could be immobilized by the mobile phase (Swadesh, 2001; Wu, 2004). As 
similar to the others chromatography’s, comparing the cytotoxicity assays from these 
fractions, it was verified that the active fractions possess very low masses. Given this, 
performing a purification of each fraction with such low masses, is challenging, risking 
some compounds to be retained in the stationary phase of the HPLC column and losing 
mass. As was describe before, the active fractions were collected into a single pool, 
hoping with this to obtain sufficient mass of the active compounds to perform its isolation. 
The chromatograph profile revealed this mixture to be too much complex to perform an 
efficient fractionation through HPLC technique. Increasing the VLC and HPLC resolution 
could be achieved by changing the polarity gradient more slowly, more specifically in the 
polarity region where are located the active compounds.  
The NMR profile of PTACES showed that this fraction was too complex to verify the type 
of compounds present in the mixture. However, the presence of doublets at 7.90 δ, 7.59 δ 
and quartet 7.10 δ, demonstrated the possibility of similar compounds being present in the 
same fractions. In fact, these peaks were crucial along with the cytotoxic assays to decide 
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to collect the fraction between 12-19 in a single mixture to have sufficient mass, and so to 
perform a chromatography to isolate the present active compounds. Related with NMR 
analyses, a research on the literature revealed that the presence of the singlets at 7.36 δ 
and 3.49 δ are coincident with existence of chloroform and methanol in the fractions, 
respectively.(Fulmer et al., 2010). The presence of chloroform can be justified since the 
fractions were dissolved in this solvent to be subjected to an NMR analyses. Although, the 
presence of methanol was considered a contaminant, with a possible origin on deficient 
wash of the NMR tubes or even inadequate evaporation, resulting in traces of this solvent 
in the extracts. 
The chromatograms confirm the results from NMR analysis. The collection of the fractions 
between 12-19 was a mixture of diverse compounds, revealing to be very challenging to 
perform isolation and identification with such low masses. The chromatogram A (Figure 
16) with an isocratic mixture of 100% revealed that most of the compounds passed in the 
HPLC detector between 6:00 min and 21:00 min, in such way to be ineffective to perform 
the isolation of each substance. Yet, the NMR analysis suggested that some compounds 
share the same chemical template, which has led to group fractions that potentially 
contain different components. The complexity of this mixture of substances posed a 
challenge and questions if this procedure was the ideal. To minimize reaching to this dead 
end, it is imperative to increase the extraction efficiency, to recover more mass (more 
precisely in the active fractions), diminishing the possibility of losing mass and finally 
elaborate an appropriate method of fractioning, with a special emphasis on the polarity 
gradient corresponding the most active fractions. 
The aim of performing a cell viability assay was with purpose of guide the fractionation 
process. In a general view, all the extractions possess compounds that can reduce the 
cellular viability. Firstly, it is important to assert that there are some variables that can 
influence the resolution of the chromatography and the time of retention in the stationary 
phase (ex. impurities, temperature, the operator skill etc.), proving the reproductive of this 
process being very difficult. In other words, the active compound can be present in a 
varied concentration in the different fractions according with the extract. These 
phenomena can be observed by the fact of the same fractions of E15094, PT01 and 
E16152, show different cellular viability, when even exposed to same cell lines and 
concentration. Besides this, a pattern is found when looking to the more bioactive 
fractions. The cell lines were more sensitive with the fractions between D and G, leading 
to conclude the presence of compounds with high ability to reduce the cellular viability. 
Comparing the impact of the cell viability in the cancer and normal cells, it is verified that 
they are both affected by the active compounds. Although, some fraction showed to be 
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more toxics to the cancer cells than the normal ones. Observing the cell viability data 
obtained in the fraction E from E16152, the HEPG2 cells are clearly more affected than 
the HCMEC/D3 after a treatment of 1µg /ml with 72 h of exposure. The same effects are 
evident, by spotting the toxicity induced by the fraction 8 in the HCMEC/D3 and HEPG2 
cell lines. The absence of toxic impact in the normal cell, contrasting with the low cellular 
viability in cancer lines, proposes the possibility of the presence of active compounds with 
selectivity toward HEPG2. The results corroborate the data presented by (Alves et al., 
2015), when the author suggest that the active compounds could be more toxic to the 
cancer cells. The other explanation for this difference of cell viability between cancer and 
normal cells is the metabolic rate. The cancer cells are well known for having a higher 
metabolic rate, with a high glucose consumption to boost tumor proliferation, through a 
phenomenon designated Warburg effect. (Cairns, Harris, & Mak, 2011; DeBerardinis, 
2008). Giving this, the cancer lines can absorb more nutrients (including the bioactive 
compounds) and so, present the toxic effects early and more acutely. The percentage of 
viable cells was obtained through an MTT assay. Some author question if the results 
obtained though this colorimetric test could be considered reliable. The reduction of MTT 
into its formazan is dependable on cell metabolic rate. Consequently, cells that divide 
slowly will exhibit slow MTT reduction rates, when on other hand, cells with a high 
metabolism will reduce the MTT more faster. (van Tonder, Joubert, & Cromarty, 2015).  
Meanwhile, MTT test is a good assay for preliminary screening for bioactive compounds 
(as was design in this study) and to detect a direct impact in the cell metabolic activity. 
However, with the limitations of test, the toxicity of the bioactive compounds should be 
confirmed with other assay as lactate dehydrogenase (LDH) test, providing information 
about the integrity of the cellular membranes. 
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6. Conclusion 
 
As referred, there has been a big demand for the search of new compounds, that can be 
key to fight illness, such as cancer or obesity or problematic issues as the microbial 
resistance to the antibiotics. With this, fungi emerge as great sources of bioactive 
compounds for giving response to these challenging issues, as solution to other 
biomedical topics. Giving the lack of data about the bioactive potential of spores of P. 
tinctorius, Alves et al. (2015) opened a new chapter by confirming the existence of 
compounds in this structures able to affect the cell viability, and with a remarkable 
cytotoxicity in the cancer cell lines. However, giving the natures of the spores as 
resistance structures, it was difficult to perform an extraction with a substantial recovery of 
mass. The study conducted on this thesis tried to give an answer to the low efficiency 
extraction problem, and at the same time attempt to obtain more data about the bioactive 
compounds present in the spores. The results obtained confirm that the spores of P. 
tinctorius can be a useful source of bioactive compounds, more specifically, with 
anticancer potential. Although it was not possible to identify the compound(s) responsible 
for this cytotoxicity, the extraction method was improved, confirming that the glass beads 
are a useful tool to force the lysis of strong structures, opening a door for upgrades in this 
technique, since it is imperative to improve the extraction yield. However, further research 
efforts must be conducted to identify and isolate the compounds responsible for 
cytotoxicity effect and respective mechanisms of action. Giving this anticancer effect, it 
would be interesting to study the spores as a potential source for new compounds with 
bioactive properties in different fields (ex. anti-inflammatory, anti-microbial, etc.).
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7.  Appendixes 
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7.1 Appendix A- 1H NMR data for sub-fractions resulting from 
PTAFCES. 
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Figure 1. NMR spectrum from fraction 1 of PTAFCES in CDCL3 (recorded at 600 
MHz) 
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Figure 2. NMR spectrum from fraction 2 of PTAFCES in CDCL3 (recorded at 600 
MHz) 
Figure 3. NMR spectrum from fraction 3 of PTAFCES in CDCL3 (recorded at 600 
MHz) 
 52 
 
 
 
 
 
 
 
 
Figure 5. NMR spectrum from fraction 5 of PTAFCES in CDCL3 (recorded at 600 
MHz) 
Figure 4. NMR spectrum from fraction 4 of PTAFCES in CDCL3 (recorded at 600 
MHz) 
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Figure 7. NMR spectrum from fraction 7 of PTAFCES in CDCL3 (recorded at 600 
MHz) 
Figure 6. NMR spectrum from fraction 6 of PTAFCES in CDCL3 (recorded at 600 
MHz) 
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Figure 8. NMR spectrum from fraction 8 of PTAFCES in CDCL3 (recorded at 600 
MHz) 
Figure 9. NMR spectrum from fraction 9 of PTAFCES in CDCL3 (recorded at 600 
MHz) 
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Figure 10. NMR spectrum from fraction 10 of PTAFCES in CDCL3 (recorded at 
600 MHz) 
Figure 11. NMR spectrum from fraction 11 of PTAFCES in CDCL3 (recorded at 
600 MHz) 
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Figure 12. NMR spectrum from fraction 12 of PTAFCES in CDCL3 (recorded at 
600 MHz) 
Figure 13. NMR spectrum from fraction 13 of PTAFCES in CDCL3 (recorded at 
600 MHz) 
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Figure 14. NMR spectrum from fraction 14 of PTAFCES in CDCL3 (recorded at 
600 MHz) 
Figure 15. NMR spectrum from fraction 15 of PTAFCES in CDCL3 (recorded at 
600 MHz) 
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Figure 16 NMR spectrum from fraction 16 of PTAFCES in CDCL3 (recorded at 
600 MHz) 
Figure 17 NMR spectrum from fraction 17 of PTAFCES in CDCL3 (recorded at 
600 MHz) 
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 Figure 19 NMR spectrum from fraction 19 of PTAFCES in CDCL3 (recorded at 
600 MHz) 
Figure 18 NMR spectrum from fraction 18 of PTAFCES in CDCL3 (recorded at 
600 MHz) 
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 Figure 21 NMR spectrum from fraction 21 of PTAFCES in CDCL3 (recorded at 
600 MHz) 
Figure 20 NMR spectrum from fraction 20 of PTAFCES in CDCL3 (recorded at 
600 MHz) 
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Figure 22 NMR spectrum from fraction 22 of PTAFCES in CDCL3 (recorded at 
600 MHz) 
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7.2 Appendix B - Effects of fractions from E16151 at 20µg/ml 
in the viability of HEPG2 (A) and HDMC (B) 
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Figure 15. Effects of fractions from PTAFCES at 20µg/ml in the viability of 
HEPG2 (A) and HDMC (B). Values are present as means ±SD of triplicate analyses 
when compared with control group (n = 3). 
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